Mangalam Organics Limited (NSE:MANORG)
India · Delayed Price · Currency is INR 607.05
-0.50 (-0.08%)
Aug 22, 2025, 3:29 PM IST
Mangalam Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 5,586 | 5,300 | 4,935 | 4,925 | 4,906 | 3,382 | Upgrade |
Other Revenue | - | - | - | - | 10.06 | 3.64 | Upgrade |
| 5,586 | 5,300 | 4,935 | 4,925 | 4,917 | 3,386 | Upgrade | |
Revenue Growth (YoY) | 11.14% | 7.39% | 0.20% | 0.18% | 45.20% | -9.59% | Upgrade |
Cost of Revenue | 2,696 | 2,735 | 3,050 | 3,463 | 2,847 | 1,345 | Upgrade |
Gross Profit | 2,890 | 2,565 | 1,885 | 1,462 | 2,069 | 2,041 | Upgrade |
Selling, General & Admin | 430.82 | 415.38 | 475.09 | 381.53 | 434.17 | 303.81 | Upgrade |
Other Operating Expenses | 1,766 | 1,564 | 1,023 | 1,100 | 714.02 | 452.4 | Upgrade |
Operating Expenses | 2,407 | 2,188 | 1,696 | 1,657 | 1,298 | 891.55 | Upgrade |
Operating Income | 483.3 | 377.62 | 188.42 | -194.65 | 771.02 | 1,149 | Upgrade |
Interest Expense | -232.73 | -214.77 | -151.65 | -129.68 | -31.66 | -5.96 | Upgrade |
Interest & Investment Income | - | - | 3.44 | 0.3 | 4.35 | 6.85 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0.88 | -8.32 | -1.13 | -3.3 | Upgrade |
Other Non Operating Income (Expenses) | 41.58 | 3.34 | -1.11 | -5.13 | -10.32 | -4.06 | Upgrade |
EBT Excluding Unusual Items | 292.15 | 166.2 | 39.99 | -337.47 | 732.27 | 1,143 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.13 | -0.12 | -0.18 | - | Upgrade |
Pretax Income | 292.15 | 166.2 | 39.86 | -337.6 | 732.09 | 1,143 | Upgrade |
Income Tax Expense | 60.6 | 40.23 | -3 | -65.35 | 194.66 | 295.21 | Upgrade |
Earnings From Continuing Operations | 231.55 | 125.97 | 42.86 | -272.25 | 537.43 | 847.79 | Upgrade |
Minority Interest in Earnings | - | - | 1.2 | - | - | - | Upgrade |
Net Income | 231.55 | 125.97 | 44.06 | -272.25 | 537.43 | 847.79 | Upgrade |
Net Income to Common | 231.55 | 125.97 | 44.06 | -272.25 | 537.43 | 847.79 | Upgrade |
Net Income Growth | 309.70% | 185.88% | - | - | -36.61% | 76.86% | Upgrade |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Change (YoY) | -1.19% | 0.74% | - | - | - | - | Upgrade |
EPS (Basic) | 26.84 | 14.60 | 5.15 | -31.79 | 62.75 | 98.99 | Upgrade |
EPS (Diluted) | 26.84 | 14.60 | 5.15 | -31.79 | 62.75 | 98.99 | Upgrade |
EPS Growth | 314.64% | 183.77% | - | - | -36.61% | 76.86% | Upgrade |
Free Cash Flow | - | -751.15 | 327.48 | 361.57 | -1,841 | -27.6 | Upgrade |
Free Cash Flow Per Share | - | -87.06 | 38.24 | 42.22 | -214.92 | -3.22 | Upgrade |
Dividend Per Share | - | - | - | - | 1.500 | 1.500 | Upgrade |
Dividend Growth | - | - | - | - | - | 50.00% | Upgrade |
Gross Margin | 51.74% | 48.40% | 38.19% | 29.69% | 42.09% | 60.28% | Upgrade |
Operating Margin | 8.65% | 7.12% | 3.82% | -3.95% | 15.68% | 33.95% | Upgrade |
Profit Margin | 4.15% | 2.38% | 0.89% | -5.53% | 10.93% | 25.04% | Upgrade |
Free Cash Flow Margin | - | -14.17% | 6.64% | 7.34% | -37.44% | -0.81% | Upgrade |
EBITDA | 693.92 | 585.79 | 386.78 | -19.2 | 921.21 | 1,285 | Upgrade |
EBITDA Margin | 12.42% | 11.05% | 7.84% | -0.39% | 18.74% | 37.94% | Upgrade |
D&A For EBITDA | 210.62 | 208.17 | 198.36 | 175.45 | 150.19 | 135.34 | Upgrade |
EBIT | 483.3 | 377.62 | 188.42 | -194.65 | 771.02 | 1,149 | Upgrade |
EBIT Margin | 8.65% | 7.12% | 3.82% | -3.95% | 15.68% | 33.95% | Upgrade |
Effective Tax Rate | 20.74% | 24.20% | - | - | 26.59% | 25.83% | Upgrade |
Revenue as Reported | 5,627 | 5,303 | 4,943 | 4,929 | 4,921 | 3,393 | Upgrade |
Advertising Expenses | - | - | 84.41 | 34.57 | 136.81 | 34.68 | Upgrade |
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.